Notice: This company has been marked as potentially delisted and may not be actively trading. Innovate Biopharmaceuticals (INNT) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrends INNT vs. VAXX, SCPS, AMPE, ARDS, STAB, CMRA, EVLO, EFTR, AEHAW, and CLVRShould you be buying Innovate Biopharmaceuticals stock or one of its competitors? The main competitors of Innovate Biopharmaceuticals include Vaxxinity (VAXX), Scopus BioPharma (SCPS), Ampio Pharmaceuticals (AMPE), Aridis Pharmaceuticals (ARDS), Statera Biopharma (STAB), Comera Life Sciences (CMRA), Evelo Biosciences (EVLO), eFFECTOR Therapeutics (EFTR), Aesther Healthcare Acquisition (AEHAW), and Clever Leaves (CLVR). Innovate Biopharmaceuticals vs. Vaxxinity Scopus BioPharma Ampio Pharmaceuticals Aridis Pharmaceuticals Statera Biopharma Comera Life Sciences Evelo Biosciences eFFECTOR Therapeutics Aesther Healthcare Acquisition Clever Leaves Innovate Biopharmaceuticals (NASDAQ:INNT) and Vaxxinity (NASDAQ:VAXX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, earnings, profitability, community ranking, dividends, risk, analyst recommendations and institutional ownership. Which has more volatility & risk, INNT or VAXX? Innovate Biopharmaceuticals has a beta of -0.39, meaning that its share price is 139% less volatile than the S&P 500. Comparatively, Vaxxinity has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500. Which has higher valuation & earnings, INNT or VAXX? Innovate Biopharmaceuticals has higher earnings, but lower revenue than Vaxxinity. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInnovate BiopharmaceuticalsN/AN/A-$27.05MN/AN/AVaxxinity$70K0.36-$56.93M-$0.450.00 Does the media prefer INNT or VAXX? In the previous week, Innovate Biopharmaceuticals' average media sentiment score of 0.00 equaled Vaxxinity'saverage media sentiment score. Company Overall Sentiment Innovate Biopharmaceuticals Neutral Vaxxinity Neutral Does the MarketBeat Community believe in INNT or VAXX? Innovate Biopharmaceuticals received 198 more outperform votes than Vaxxinity when rated by MarketBeat users. Likewise, 65.48% of users gave Innovate Biopharmaceuticals an outperform vote while only 38.46% of users gave Vaxxinity an outperform vote. CompanyUnderperformOutperformInnovate BiopharmaceuticalsOutperform Votes20365.48% Underperform Votes10734.52% VaxxinityOutperform Votes538.46% Underperform Votes861.54% Is INNT or VAXX more profitable? Company Net Margins Return on Equity Return on Assets Innovate BiopharmaceuticalsN/A N/A -234.42% Vaxxinity N/A N/A N/A Do insiders and institutionals believe in INNT or VAXX? 5.9% of Innovate Biopharmaceuticals shares are owned by institutional investors. Comparatively, 83.0% of Vaxxinity shares are owned by institutional investors. 7.9% of Innovate Biopharmaceuticals shares are owned by company insiders. Comparatively, 64.1% of Vaxxinity shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryVaxxinity beats Innovate Biopharmaceuticals on 6 of the 9 factors compared between the two stocks. Ad DTIWhen it comes to NVDA… “acceleration cycles” are the keyExpert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! Get Innovate Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for INNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INNT vs. The Competition Export to ExcelMetricInnovate BiopharmaceuticalsPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$8,000.00$6.53B$5.10B$8.84BDividend YieldN/A8.11%5.04%4.07%P/E Ratio-1.795.5095.1214.22Price / SalesN/A375.021,217.3088.42Price / CashN/A52.5939.4936.27Price / BookN/A10.276.976.37Net Income-$27.05M$153.22M$118.73M$225.56M Innovate Biopharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INNTInnovate BiopharmaceuticalsN/AN/AN/AN/A$8,000.00N/A-1.798VAXXVaxxinityN/A$0.00flatN/A-100.0%$25,000.00$70,000.000.0090SCPSScopus BioPharmaN/A$0.00flatN/A-99.3%$13,000.00N/A0.009AMPEAmpio PharmaceuticalsN/A$0.01+∞N/A-99.6%$11,000.00N/A0.0020Gap DownARDSAridis PharmaceuticalsN/AN/AN/AN/A$10,000.00$3.09M0.0030STABStatera BiopharmaN/A$0.00flatN/A+0.0%$10,000.00$1.49M0.0020CMRAComera Life SciencesN/A$0.00flatN/A-99.5%$9,000.00$630,000.000.002EVLOEvelo BiosciencesN/A$0.00-66.7%N/A-99.7%$9,000.00N/A0.00120News CoverageGap DownEFTReFFECTOR Therapeutics1.2792 of 5 stars$0.00flat$24.00+11,999,900.0%-100.0%$1,000.00$3.55M0.0010Negative NewsAEHAWAesther Healthcare AcquisitionN/A$0.04-20.6%N/A-71.9%$0.00N/A0.002CLVRClever LeavesN/AN/AN/AN/A$0.00$17.42M0.00560 Related Companies and Tools Related Companies VAXX Competitors SCPS Competitors AMPE Competitors ARDS Competitors STAB Competitors CMRA Competitors EVLO Competitors EFTR Competitors AEHAW Competitors CLVR Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:INNT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovate Biopharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovate Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
